Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kunio Saito.
Cancer Science | 2010
Koji Oda; Noriko Hosoda; Hiroshi Endo; Kunio Saito; Kenji Tsujihara; Michio Yamamura; Takeshi Sakata; Naohiko Anzai; Michael F. Wempe; Yoshikatsu Kanai; Hitoshi Endou
Most tumor cell membranes overexpress l‐type amino acid transporter 1, while normal cell membranes contain l‐type amino acid transporter 2; both are Na+‐independent amino acid transporters. Therefore, compounds that selectively inhibit l‐type amino acid transporter 1 offer researchers with a novel cancer molecular target. Synthetic chemistry efforts and in vitro screening have produced a variety of novel compounds possessing high in vitrol‐type amino acid transporter 1 selectivity; KYT‐0353 was one such compound. The present studies illustrate that KYT‐0353 inhibited 14C‐leucine uptake and cell growth in human colon cancer‐derived HT‐29 cells; IC50s were 0.06 μm and 4.1 μm, respectively. KYT‐0353 also inhibited 14C‐leucine uptake in mouse renal proximal tubule cells expressing l‐type amino acid transporter 1, and inhibited cell growth; IC50s were 0.14 μm and 16.4 μm, respectively. Compared to control animals, intravenously administered KYT‐0353 (12.5 mg/kg and 25.0 mg/kg) showed statistically significant growth inhibition against HT‐29 tumors transplanted to nude mice with maximal inhibition ratios of 65.9% and 77.2%, respectively. Body weight increase with time – a safety indicator – was slightly depressed at 12.5 mg/kg and 25.0 mg/kg with maximal ratios of 3.7% (day 2) and 6.3% (day 11), respectively. Thus, KYT‐0353 showed significant growth inhibitory effects on HT‐29 cells both in vitro and in vivo, whereas it only caused a slight body weight depression. Therefore, KYT‐0353 appears to have potential as a novel anti‐tumor agent, presumably via selective in vivol‐type amino acid transporter 1 inhibition. (Cancer Sci 2009)
Synthetic Communications | 1999
Mitsuya Hongu; Kunio Saito; Kenji Tsujihara
Abstract A facile and mild glycosylation reaction in solid-liquid two-phase system (powdered K2CO3/CHCl3) containing phase transfer catalyst was found to be efficient for preparation of glucosides of 2′, 6′-dihydroxyacetophenone (1) and other various substituted phenols.
Journal of Medicinal Chemistry | 1999
Kenji Tsujihara; Mitsuya Hongu; Kunio Saito; Hiroyuki Kawanishi; Kayoko Kuriyama; Mamoru Matsumoto; Akira Oku; Kiichiro Ueta; Minoru Tsuda; Akira Saito
Chemical & Pharmaceutical Bulletin | 1996
Kenji Tsujihara; Mitsuya Hongu; Kunio Saito; Masanori Inamasu; Kenji Arakawa; Akira Oku; Mamoru Matsumoto
Archive | 1997
Mitsuya Hongu; Mamoru Matsumoto; Akira Oku; Kunio Saito; Kenji Tsujihara
Chemical & Pharmaceutical Bulletin | 1998
Mitsuya Hongu; Takashi Tanaka; Nobuyuki Funami; Kunio Saito; Kenji Arakawa; Mamoru Matsumoto; Kenji Tsujihara
Archive | 2003
Hitoshi Endo; Yoshikatsu Kanai; Kenji Tsujihara; Kunio Saito
Chemical & Pharmaceutical Bulletin | 1998
Mitsuya Hongu; Nobuyuki Funami; Youichi Takahashi; Kunio Saito; Kenji Arakawa; Mamoru Matsumoto; Hirokazu Yamakita; Kenji Tsujihara
Archive | 1995
Kenji Tsujihara; Kunio Saito; Satoshi Furuuchi
Archive | 1997
Mamoru Matsumoto; Teruya Motomiya; Satoru Oku; Kunio Saito; Kenji Tsujihara; 光弥 本宮; 守 松本; 健二 辻原; ▲邦▼夫 齋藤